Medicaid and physician-administered drugs

Members of the Medicaid and CHIP Payment and Access Commission met publicly last week in Washington, D.C. The following is MACPAC’s own summary of its meeting. The March 2024 MACPAC meeting began with proposed recommendations on improving the transparency of Medicaid financing. The proposed recommendations are intended to improve the transparency of Medicaid financing methods, state-level financing amounts, and provider-level financing amounts. The presentation also included a recommendation to apply the proposed Medicaid financing transparency requirements to the State Children’s Health Insurance Program (CHIP). Staff reviewed the rationale for the recommendations and the implications for various stakeholders. The Commission will vote on [...]